Anna Sancho-Balsell; Sara Borràs-Pernas; Francesca Flotta; Wanqi Chen; Daniel Del Toro; Manuel J Rodríguez; Jordi Alberch; Guillaume Blivet; Jacques Touchon; Xavier Xifró; Albert Giralt "Brain-gut photobiomodulation restores cognitive alterations in chronically stressed mice through the regulation of Sirt1 and neuroinflammation." Journal of Affective Disorders 354 (2024): 574-588. Irene Solés-Tarrés; Núria Cabezas-Llobet; Benjamin Lefranc; Jérôme Leprince; Jordi Alberch; David Vaudry; Xavier Xifró "Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington's Disease Models: Role of PAC1 Receptor." Frontiers in Pharmacology 12 (2022): -. Vidal-Sancho L; Fernández-García S; Solés-Tarrés I; Alberch J; Xifró X. "Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction." Molecular Neurobiology 57 (2020): 4549-4562. Solés-Tarrés I; Cabezas-Llobet N; Vaudry D; Xifró X "Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases." Frontiers in Cellular Neuroscience 14 (2020): 221-. Núria Cabezas-Llobet; Sandra Camprubí; Beatriz García; Jordi Alberch; Xavier Xifro "Human alpha 1-antitrypsin protects neurons and glial cells against oxygen and glucose deprivation through inhibition of interleukins expression." Biochimica et Biophysica Acta. General Subjects 1862 (2018): 1852-1861. N. Cabezas-Llobet; L. Vidal-Sancho; M. Masana; A. Fournier; J. Alberch; D. Vaudry; X. Xifro "Pituitary adenylate cyclase-activating polypeptide (pacap) enhances hippocampal synaptic plasticity and improves memory performance in Huntington's disease." Molecular Neurobiology (2018): -. Anglada-Huguet M; Vidal L; Giralt A; García-Díaz Barriga G; Xifró X; Alberch J "Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity." Neurobiology of Disease 95 (2016): 22-34. Anglada-Huguet M; Giralt A; Rué L; Alberch J; Xifró X "Loss of striatal 90-KDa Ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease." Biochimica et Biophysica Acta. Molecular Basis of Disease 1862 (2016): 1255-1266. Azkona G; Saavedra A; Aira Z; Aluja D; Xifró X; Baguley T; Alberch J; Ellman JA; Lombroso PJ; Azkue JJ; Pérez-Navarro E "STEP modulates nociception: evidences from genetic deletion and pharmacological inhibition." Pain 157 (2016): 377-386. Xifró X., Vidal-Sancho L., Boadas-Vaello P., Turrado C., Alberch J., Puig T., Verdú E "Novel Epigallocatechin-3-Gallate (EGCG) Derivative as a New Therapeutic Strategy for Reducing Neuropathic Pain after Chronic Constriction Nerve Injury in Mice." PLoS One 10 (2015): e0123122-. Anglada-Huguet M; Xifró X; Giralt A; Zamora-Moratalla A; Martín ED; Alberch J "Prostaglandin E2 EP1 Receptor Antagonist Improves Motor Deficits and Rescues Memory Decline in R6/1 Mouse Model of Huntington's Disease.." Molecular Neurobiology (2014): 784-795. Xifro X; Miñano-Molina AJ; Saura CA; Rodríguez-Álvarez J "Ras activation is a key event in activity-dependent survival of cerebellar granule neurons." Journal of Biological Chemistry (2014): -. Xavier Xifró;Teresa Puig;Pere Boadas-Vaello "Diagnosis and pharmacological treatment of neuropathic pain in spinal cord injury subjects: from laboratory to clinical trial." Medicina Clinica 140 (2013): 175-181. Anglada-Huguet M; Giralt A; Pérez-Navarro E; Alberch J; Xifró X "Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease.." Journal of Neurochemistry 121 (2012): 639-648. Xifro X; Anglada-Huguet M; Rue L; Saavedra A; Perez-Navarro E; Alberch J "Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity." Molecular Neurodegeneration 6 (2011): 74-. Saavedra A; Giralt A; Rué L; Xifró X; Xu J; Ortega Z; Lucas JJ; Lombroso PJ; Alberch J; Pérez-Navarro E "Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity." Journal of Neuroscience 31 (2011): 8150-8162. Giralt A; Saavedra A; Carretón O; Xifró X; Alberch J; Pérez-Navarro E "Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease." Human Molecular Genetics 20 (2011): 4232-4247. del Toro D; Xifró X; Pol A; Humbert S; Saudou F; Canals JM; Alberch J "Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease." Journal of Neurochemistry 115 (2010): 153-167. Saavedra A; Garcia-Martinez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Diaz-Hernandez M; Lucas JJ; Alberch J; Perez-Navarro E "PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of PI3K/Akt prosurvival pathway in Huntington's disease." Cell Death and Differentiation 17 (2010): 324-335. Graus F; Boronat A; Xifró X; Boix M; Svigelj V; García A; Palomino A; Sabater L; Alberch J; Saiz A "The expanding clinical profile of anti-AMPA receptor encephalitis." Neurology 74 (2010): 857-859. Barneda-Zahonero B; Miñano AJ; Badiola N; Fado R; Xifró X; Saura CA; Rodríguez-Álvarez J "Bone Morphogenetic Protein-6 promotes cerebellar granule neurons survival by activation of the MEK/ERK/CREB pathway." Molecular Biology of the Cell 20 (2009): 5051-5063. del Toro D; Alberch J; Perez F; Martin-Ibañez R; Xifró X; Egea G; Canals JM "Mutant Huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from Golgi Apparatus." Molecular Biology of the Cell (2009): -. Xifró X; Giralt A; Saavedra A; Garcia-Martinez JM; Diaz-Hernandez M; Lucas JJ; Alberch J; Perez-Navarro E "Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: Role in excitotoxicity." Neurobiology of Disease 36 (2009): 461-469. Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E "Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells." Journal of Neurochemistry 105 (2008): 1596-1612. Sabater L; Xifró X; Saiz A; Alberch J; Graus F "Analysis of antibodies to neuronal surface antigens in adult opsoclonus-myoclonus." Journal of Neuroimmunology 196 (2008): 188-191. Minano A; Xifró X; Pérez V; Barneda-Zahonero B; Saura CA; Rodríguez-Álvarez J "Estradiol facilitates neurite* *maintenance by a Src/Ras/ERK signalling pathway**." Molecular and Cellular Neuroscience 39 (2008): 143-151. Minano A; Cerbon MA; Xifró X; Malagelada C; Aguilera J; Rodríguez-Álvarez J "17beta-estradiol does not protect cerebellar granule cells from neither excitotoxicity nor apoptosis." Journal of Neurochemistry 102 (2007): 354-364. García-Martinez JM; Perez-Navarro E; Xifró X; Canals JM; Diaz-Hernandez M; Trioulier Y; Brouillet E; Lucas JJ; Alberch J "BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease." Journal of Neuroscience Research 85 (2007): 2756-2769. Xifró X; Falluel-Morel A; Minano A; Aubert N; Malagelada C; Vaudry D; Vaudry H; Gonzalez BJ; Rodríguez-Álvarez J "NMDA blocks activation of JNK and mitochondrial apoptotic pathway induced by potassium deprivation in cerebellar granule cells." the journal of biological chemistry 281 (2006): 6801-6812. Aubert N; Falluel-Morel A; Vaudry D; Xifró X; Rodriguez-Alvarez J; Fisch C; deJouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ "PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-fos in PACAP-induced Bcl-2 expression." Journal of Neurochemistry 99 (2006): 1237-1250. Xifró X; Malagelada C; Minano A; Rodríguez-Álvarez J "Brief exposition to NMDA protects cerebellar granule cells from apoptosis by a protein-kinases mediated inhibition of caspase-3." European Journal of Neuroscience 21 (2005): 827-840. Malagelada C; Xifró X; Minano AJ; Sabria J; Rodriguez-Alvarez J "Contribution of caspase-mediated apoptosis to the cell death caused by oxygen-glucose deprivation in cortical cell cultures." Neurobiology of Disease 20 (2005): 27-37. Malagelada C; Xifró X; Badiola N; Sabrià J; Rodríguez-Álvarez J "Histamine H2-receptor antagonist ranitidine protects against neural death induced by oxygen-glucose deprivation." Stroke 35 (2004): 2396-2401.
Xifró X., Rodríguez-Álvarez J "Delineating the factors and cellular mechanisms involved in the survival of cerebellar granule neurons." Cerebellum 14 (2015): 354-359.